These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
80 related articles for article (PubMed ID: 9168059)
21. Revised exon-intron structure of human JAK3 locus. Brooimans RA; van der Slot AJ; van den Berg AJ; Zegers BJ Eur J Hum Genet; 1999; 7(7):837-40. PubMed ID: 10573019 [TBL] [Abstract][Full Text] [Related]
22. Molecular characterization, tissue expression, and mapping of a novel Siglec-like gene (SLG2) with three splice variants. Yousef GM; Ordon MH; Foussias G; Diamandis EP Biochem Biophys Res Commun; 2001 Jun; 284(4):900-10. PubMed ID: 11409878 [TBL] [Abstract][Full Text] [Related]
23. Reconstitution of early lymphoid proliferation and immune function in Jak3-deficient mice by interleukin-3. Brown MP; Nosaka T; Tripp RA; Brooks J; van Deursen JM; Brenner MK; Doherty PC; Ihle JN Blood; 1999 Sep; 94(6):1906-14. PubMed ID: 10477719 [TBL] [Abstract][Full Text] [Related]
24. Sustained retroviral gene marking and expression in lymphoid and myeloid cells derived from transduced hematopoietic progenitor cells. Plavec I; Voytovich A; Moss K; Webster D; Hanley MB; Escaich S; Ho KE; Böhnlein E; DiGiusto DL Gene Ther; 1996 Aug; 3(8):717-24. PubMed ID: 8854097 [TBL] [Abstract][Full Text] [Related]
25. In vitro correction of JAK3-deficient severe combined immunodeficiency by retroviral-mediated gene transduction. Candotti F; Oakes SA; Johnston JA; Notarangelo LD; O'Shea JJ; Blaese RM J Exp Med; 1996 Jun; 183(6):2687-92. PubMed ID: 8676091 [TBL] [Abstract][Full Text] [Related]
26. Leukemic stem cells in childhood high-risk ALL/t(9;22) and t(4;11) are present in primitive lymphoid-restricted CD34+CD19- cells. Hotfilder M; Röttgers S; Rosemann A; Schrauder A; Schrappe M; Pieters R; Jürgens H; Harbott J; Vormoor J Cancer Res; 2005 Feb; 65(4):1442-9. PubMed ID: 15735032 [TBL] [Abstract][Full Text] [Related]
27. Molecular modeling of the Jak3 kinase domains and structural basis for severe combined immunodeficiency. Vihinen M; Villa A; Mella P; Schumacher RF; Savoldi G; O'Shea JJ; Candotti F; Notarangelo LD Clin Immunol; 2000 Aug; 96(2):108-18. PubMed ID: 10900158 [TBL] [Abstract][Full Text] [Related]
28. Expression of FLT3 receptor and response to FLT3 ligand by leukemic cells. Drexler HG Leukemia; 1996 Apr; 10(4):588-99. PubMed ID: 8618433 [TBL] [Abstract][Full Text] [Related]
29. [Long-term expansion of T cell progenitors by JAK3 gene transduced primitive hematopoietic cells in vitro]. Zhao SM; Gu XC; Chang NB; Xu XD; Peng MT Zhonghua Yi Xue Za Zhi; 2006 Jun; 86(24):1701-5. PubMed ID: 16854326 [TBL] [Abstract][Full Text] [Related]
30. Molecular cloning of a novel non-receptor tyrosine kinase, HYL (hematopoietic consensus tyrosine-lacking kinase). Sakano S; Iwama A; Inazawa J; Ariyama T; Ohno M; Suda T Oncogene; 1994 Apr; 9(4):1155-61. PubMed ID: 8134117 [TBL] [Abstract][Full Text] [Related]
31. Molecular cloning, expression pattern, and chromosomal localization of human CDKN2D/INK4d, an inhibitor of cyclin D-dependent kinases. Okuda T; Hirai H; Valentine VA; Shurtleff SA; Kidd VJ; Lahti JM; Sherr CJ; Downing JR Genomics; 1995 Oct; 29(3):623-30. PubMed ID: 8575754 [TBL] [Abstract][Full Text] [Related]
32. Structure and expression of the rat relaxin-like factor (RLF) gene. Spiess AN; Balvers M; Tena-Sempere M; Huhtaniemi I; Parry L; Ivell R Mol Reprod Dev; 1999 Dec; 54(4):319-25. PubMed ID: 10542371 [TBL] [Abstract][Full Text] [Related]
33. Peripheral expression of Jak3 is required to maintain T lymphocyte function. Thomis DC; Berg LJ J Exp Med; 1997 Jan; 185(2):197-206. PubMed ID: 9016869 [TBL] [Abstract][Full Text] [Related]
34. Murine txk: a protein tyrosine kinase gene regulated by T cell activation. Sommers CL; Huang K; Shores EW; Grinberg A; Charlick DA; Kozak CA; Love PE Oncogene; 1995 Jul; 11(2):245-51. PubMed ID: 7542761 [TBL] [Abstract][Full Text] [Related]
35. The mouse relaxin-like factor gene and its promoter are located within the 3' region of the JAK3 genomic sequence. Koskimies P; Spiess AN; Lahti P; Huhtaniemi I; Ivell R FEBS Lett; 1997 Dec; 419(2-3):186-90. PubMed ID: 9428631 [TBL] [Abstract][Full Text] [Related]
36. Molecular cloning and chromosomal mapping of a candidate cytokine gene selectively expressed in human CD34+ cells. Liu X; Rapp N; Deans R; Cheng L Genomics; 2000 May; 65(3):283-92. PubMed ID: 10857752 [TBL] [Abstract][Full Text] [Related]
37. High-level expression of a novel epitope of CD59 identifies a subset of CD34+ bone marrow cells highly enriched for pluripotent stem cells. Hill B; Rozler E; Travis M; Chen S; Zannetino A; Simmons P; Galy A; Chen B; Hoffman R Exp Hematol; 1996 Jul; 24(8):936-43. PubMed ID: 8690053 [TBL] [Abstract][Full Text] [Related]
38. Molecular cloning and analysis of the human Tec protein-tyrosine kinase. Sato K; Mano H; Ariyama T; Inazawa J; Yazaki Y; Hirai H Leukemia; 1994 Oct; 8(10):1663-72. PubMed ID: 7934162 [TBL] [Abstract][Full Text] [Related]
39. Molecular analysis of the IL-2 receptor beta chain gene expressed in human tumor cells. Suminami Y; Kashii Y; Law JC; Lin WC; Stanson J; Reichert TE; Rabinowich H; Whiteside TL Oncogene; 1998 Mar; 16(10):1309-17. PubMed ID: 9546432 [TBL] [Abstract][Full Text] [Related]
40. Self-selection by genetically modified committed lymphocyte precursors reverses the phenotype of JAK3-deficient mice without myeloablation. Bunting KD; Lu T; Kelly PF; Sorrentino BP Hum Gene Ther; 2000 Nov; 11(17):2353-64. PubMed ID: 11096440 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]